Notable companies
The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV), Medtronic plc (NYSE:MDT), Bristol-Myers Squibb Co (NYSE:BMY), Boston Scientific Corp (NYSE:BSX).
Industry description
The investment seeks to maximize total return.
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Market Cap
The average market capitalization across the iShares Health Innovation Active ETF ETF is 33.92B. The market cap for tickers in the group ranges from 75.27M to 380.22B. JNJ holds the highest valuation in this group at 380.22B. The lowest valued company is TCRX at 75.27M.
High and low price notable news
The average weekly price growth across all stocks in the iShares Health Innovation Active ETF ETF was 24%. For the same ETF, the average monthly price growth was 56%, and the average quarterly price growth was 81%. PTCT experienced the highest price growth at 28%, while VIR experienced the biggest fall at -17%.
Volume
The average weekly volume growth across all stocks in the iShares Health Innovation Active ETF ETF was 6%. For the same stocks of the ETF, the average monthly volume growth was 26% and the average quarterly volume growth was 57%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 58
P/E Growth Rating: 76
Price Growth Rating: 56
SMR Rating: 74
Profit Risk Rating: 79
Seasonality Score: 7 (-100 ... +100)